G Protein-Coupled Receptor Signaling Mechanisms

G protein-coupled receptors (GPCRs) constitute the largest family of membrane-embedded signalling proteins in humans, mediating responses to hormones, neurotransmitters, sensory stimuli and environmental cues. Their hallmark architecture of seven transmembrane helices undergoes conformational rearrangements upon ligand binding at orthosteric or allosteric sites, enabling engagement of heterotrimeric G proteins and arrestins. Activated G proteins dissociate into Gα and Gβγ subunits, each regulating effectors such as adenylyl cyclases, phospholipases and ion channels to generate second messengers (for example cyclic AMP or inositol trisphosphate). Signal termination is achieved by G protein-coupled receptor kinases (GRKs) that phosphorylate activated receptors and by β-arrestins that sterically block further G protein coupling, promote receptor internalisation and bias signalling toward alternative pathways. Advances in structural biology have revealed ligand-specific conformational ensembles that underlie functional selectivity, or ‘biased agonism’, wherein compounds preferentially trigger either G protein- or arrestin-dependent responses. Emerging insights into subcellular GPCR pools indicate that internalised receptors can continue to signal from endosomes or Golgi compartments, yielding spatially and temporally distinct outputs. Collectively, these discoveries illuminate the versatile nature of GPCR signal transduction, with direct implications for rational drug design and therapeutic intervention across cardiovascular, neurological and metabolic disorders.

Research from Nature Portfolio

Selective chemical tools have been developed to probe individual G protein subfamilies. A notable example is a plant-derived depsipeptide that acts as a highly selective inhibitor of Gq family members over other Gα isoforms. Detailed mechanistic studies demonstrated how the compound locks Gq in an inactive state, preventing nucleotide exchange and downstream effector activation. Application of this inhibitor in melanoma cell models revealed suppression of proliferative and migratory behaviours central to tumour malignancy, highlighting the potential of subtype-specific G protein blockade as a strategy for targeting oncogenic signalling.

G Protein-Coupled Receptor Signaling Mechanisms publication trend

The graph below shows the total number of articles in g protein-coupled receptor signaling mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

G protein-coupled receptor (GPCR): Seven-transmembrane protein that transmits extracellular ligand binding into intracellular signalling.

Heterotrimeric G protein: Complex of Gα, Gβ and Gγ subunits that dissociates upon receptor activation to regulate effector enzymes.

Orthosteric site: Primary ligand-binding pocket that recognises endogenous agonists or antagonists.

Allosteric site: Topographically distinct receptor region where modulators influence receptor conformation and function.

β-arrestin: Multifunctional adaptor that binds phosphorylated GPCRs to terminate G protein signalling and initiate alternative pathways.

Biased agonism: Phenomenon whereby ligands selectively stabilise receptor conformations that favour certain downstream pathways over others.

References

1. G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery. Signal Transduction and Targeted Therapy (2024).
2. Plasma membrane preassociation drives β-arrestin coupling to receptors and activation. Cell (2023).
3. Common activation mechanism of class A GPCRs. eLife (2019).
4. The experimental power of FR900359 to study Gq-regulated biological processes. Nature Communications (2015).
5. Persistent cAMP-Signals Triggered by Internalized G-Protein–Coupled Receptors. PLOS Biology (2009).